1-Prohealing coronary stent as an alternative to drug-eluting stents (DES), 2-Balloon -expandable/crush-resistant nitinol peripheral stent, 3-Nano-bas....
There’s no risk. Start your trial today to see profiles of Nexeon MedSystems (OTC:QB NXNN) (fka Paragon Intellectual Properties) plus 5517 other startups.
Start Free 7 Day Trial Now
